Meiji Seika Pharma Co., Ltd.: Meiji Seika Pharma Invests in MPM BioImpact's New Technologies and Virology Strategy
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo; President and Representative Director: Daikichiro Kobayashi, hereinafter "Meiji") announced that the company has concluded an investment agreement wi ...
Le Lézard36m
Meiji Seika Pharma Invests in MPM BioImpact's New Technologies and Virology Strategy
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo; President and Representative Director: Daikichiro Kobayashi, hereinafter "Meiji") announced that the company has concluded an investment agreement ...